AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19.

S, Gupta; SG, Coca; L, Chan; ML, Melamed; SK, Brenner; SS, Hayek; SS, Hayek; A, Sutherland; S, Puri; A, Srivastava; A, Leonberg-Yoo; AM, Shehata; JE, Flythe; A, Rashidi; EJ, Schenck; N, Goyal; SS, Hedayati; R, Dy; A, Bansal; A, Athavale; HB, Nguyen; A, Vijayan; DM, Charytan; CE, Schulze; MJ, Joo; AN, Friedman; J, Zhang; MA, Sosa; E, Judd; JCQ, Velez; M, Mallappallil; RE, Redfern; AD, Bansal; JA, Neyra; KD, Liu; AD, Renaghan; M, Christov; MZ, Molnar; MZ, Molnar; S, Sharma; O, Kamal; JO, Boateng; SAP, Short; AJ, Admon; ME, Sise; W, Wang; CR, Parikh; DE, Leaf; DE, Leaf

doi:10.1681/asn.2020060897

Public

AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19.

Shared by NobleBlocks on Oct 16, 2020 • 12:00 AM UTC

Authors:

Gupta S

Coca SG

Chan L

Abstract

Background AKI is a common sequela of coronavirus disease 2019 (COVID-19). However, few studies have focused on AKI treated with RRT (AKI-RRT).Methods We conducted a multicenter cohort study of 3099 critically ill adults with COVID-19 admitted to intensive care units (ICUs) at 67 hospitals across th...

Subject

Dialysis

acute renal failure

risk factors

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!